H-Phe-Arg-βNA.2HCl

H-Phe-Arg-βNA.2HCl is a synthetic peptide substrate widely recognized for its role in enzymatic assays, particularly in the study of serine proteases such as trypsin and related enzymes. As a dipeptidyl derivative conjugated to β-naphthylamide, this compound is designed to facilitate the sensitive and specific detection of proteolytic activity in diverse biochemical and molecular biology contexts. Its structure incorporates phenylalanine and arginine residues, which are key recognition elements for trypsin-like proteases, while the β-naphthylamide moiety enables chromogenic or fluorogenic detection upon enzymatic cleavage. The compound's robust performance in in vitro systems makes it a valuable research tool for enzymology, substrate specificity profiling, and inhibitor screening.

Enzyme activity assays: H-Phe-Arg-βNA.2HCl is extensively utilized as a chromogenic or fluorogenic substrate in the quantitative measurement of serine protease activity. Upon cleavage by target enzymes, the β-naphthylamide group is released, producing a detectable colorimetric or fluorescent signal. This property enables precise kinetic analyses of protease function, allowing for the assessment of enzyme velocity, substrate affinity, and catalytic efficiency in purified systems, cell lysates, or biological extracts. Researchers rely on this substrate to monitor enzyme activity in real time, supporting studies in protein biochemistry and enzymology.

Substrate specificity studies: The dipeptide sequence of H-Phe-Arg-βNA.2HCl serves as an effective probe for investigating the substrate preferences of trypsin-like serine proteases. By comparing cleavage rates with structurally related substrates, scientists can elucidate the molecular determinants of enzyme-substrate recognition and map the specificity pockets of proteolytic enzymes. Such studies are instrumental in understanding protease function at a mechanistic level, informing the rational design of selective inhibitors or engineered enzymes with tailored substrate profiles.

Inhibitor screening: This peptide substrate is routinely employed in high-throughput screening assays for the identification and characterization of protease inhibitors. The sensitive detection of β-naphthylamide release enables rapid and reproducible quantification of protease activity in the presence of candidate inhibitory compounds. This application is particularly valuable in pharmaceutical research and chemical biology, where it supports the discovery and optimization of molecules targeting serine proteases implicated in physiological and pathological processes.

Biochemical pathway analysis: By serving as a selective reporter substrate, H-Phe-Arg-βNA.2HCl aids in dissecting complex proteolytic cascades within biochemical pathways. Its use allows researchers to attribute specific proteolytic events to individual enzymes or enzyme families, facilitating the mapping of protease networks in diverse biological systems. This approach is essential for unraveling the roles of proteases in processes such as signal transduction, protein maturation, and cellular regulation, thereby advancing our understanding of fundamental biological mechanisms.

Analytical method development: The compound's distinct spectroscopic properties make it an excellent choice for the development and validation of analytical methods aimed at quantifying protease activity. Its compatibility with spectrophotometric and fluorometric detection platforms ensures adaptability to various assay formats, from microplate-based high-throughput screens to detailed kinetic studies. Method developers leverage the reliable performance of this substrate to establish robust, sensitive, and reproducible protocols for protease quantification in research and industrial laboratories.

1. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

2. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

3. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

4. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

5. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet